Management of severe asthma: summary of the European Respiratory Society/American Thoracic Society task force report

Sandhya Khurana; Andrew Bush; Fernando Holguin

doi:10.1183/20734735.0058-2020

Breathe (Jun 2020)

Management of severe asthma: summary of the European Respiratory Society/American Thoracic Society task force report

Sandhya Khurana,
Andrew Bush,
Fernando Holguin

Affiliations

Sandhya Khurana: University of Rochester School of Medicine and Dentistry, Pulmonary and Critical Care Medicine, Rochester, NY, USA
Andrew Bush: Dept of Paediatrics, National Heart & Lung Institute, Imperial College London, London, UK
Fernando Holguin: University of Colorado, Pulmonary Sciences and Critical Care Medicine, Denver, CO, USA

DOI: https://doi.org/10.1183/20734735.0058-2020
Journal volume & issue: Vol. 16, no. 2

Abstract

Read online

Educational aims This article is mainly intended for trainees and specialists who are interested in the management of severe asthma. It aims to inform readers about the updated ERS/ATS recommendations for management of severe asthma, specifically on the topics of biologics, macrolides and long-acting muscarinic antagonists. It also provides guidance on utilisation of available biomarkers in selecting advanced therapies in severe asthma.

Published in Breathe

ISSN: 1810-6838 (Print); 2073-4735 (Online)
Publisher: European Respiratory Society
Country of publisher: United Kingdom
LCC subjects: Medicine: Internal medicine: Specialties of internal medicine: Diseases of the respiratory system
Website: https://breathe.ersjournals.com/

About the journal